U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07352228) titled 'Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of Cirrhotic Varices' on Dec. 25, 2025.
Brief Summary: Cirrhosis is a serious liver disease where scar tissue replaces healthy liver tissue, often leading to portal hypertension-a condition where blood pressure in the liver's blood vessels rises. A life-threatening complication of this is variceal bleeding, which happens when swollen veins (varices) in the esophagus or stomach rupture. Around 30% of patients die during their first variceal bleeding episode, and 60-70% of survivors face a high risk of rebleeding, making secondary prevention crucial for im...